Sunday, November 23, 2008

Lung cancer is increasing in women and younger ages

In Spain there are 20,000 new cases and deaths, 20%, is the highest in this type of disease. The prevention of addiction to snuff get their results on the studies in 2050. The International Consortium of the Cancer Genome responsible for our country to investigate leukemia.

Lung cancer in Spain, with 20,000 new cases annually, is declining in men and increasing in women, and is presented at earlier ages, mainly due to the consumption of snuff.

These are the main findings of the first report on "Lung cancer in Spain. Radiography 2008", presented yesterday at Zaragoza and revealed that his death is the highest of all cancers, 20 percent of the total, exceeding the sum of the deaths from breast cancer, prostate and colon.

The report was prepared by the Spanish Group of Lung Cancer (GECP), which it unveiled yesterday on the occasion of its Educational Symposium IV, in which more than 300 experts will discuss today and tomorrow the most important data of this disease in Spain and in the world.

In Spain are seeing changes in the incidence of this cancer, with a decrease in males and females and an increase in their presentation at younger ages, a trend that will continue in the coming years especially in relation to the habit of snuff, Dolores medical oncologist explained the island, the Clinical Hospital of Zaragoza, Steering Committee GECP.

The incidence of lung cancer in men is 77.4 per 100,000 inhabitants, intermediate to Europe, although it is lower in women, 8 per 100,000.

The medical oncologist Bartomeu Massuti, Alicante General Hospital, said that although it is not the more common it is that causes increased mortality, and that one in five Spaniards who is dying from cancer of the lung.

Massuti, secretary of GECP, explained that a disease is predictable, so it is necessary to reduce smoking, while at the same time said that we must be aware that the impact of the measures being taken now will be seen in terms of reduced Mortality from lung cancer since 2050.

In this connection he stressed that "the data are strong" and although Spain has been enhanced in the anti-smoking measures, it remains below the European average, and "should and can do more."

Prevention is a priority but needs some time, and the decline of smoking is essential to reduce this type of cancer, he said, while also indicated that 50 percent of those diagnosed are over 65 years, but due to early maturity in consumption of snuff are occurring already below the age of 40.

For example, he said, a man aged 35 who smoke more than twenty-five cigarettes a day for 75 years before facing a 13 percent risk of dying from lung cancer, 10 percent of coronary disease by 28 percent and related pathologies with the snuff.

In Spain, consumption of snuff has declined in men over the past ten or fifteen years, but has increased among women and is now stable.

The CEPA has created a working group to study lung cancer among women, according to the oncologist Enriqueta Felip, the Val D 'Hebron in Barcelona, who noted that of the 20,000 new cases each year in Spain in 2000 were women.

Sex differences

The characteristics of lung cancer are different in women and men, and although smoking has the same influence on the two sexes, there are studies that show that exposure to snuff as women have a higher risk of suffering from this tumor.

Between 10 percent of non-smokers who suffer from lung cancer is more common in women than in men, he added Felip, who reported to be investigating whether there are hormonal factors that may have some influence on this tumor.

In addition, women have a better prognosis since his 5-year survival is 7 to 18 percent, while in men is from 6 to 14 percent.

On the other hand, Spain is responsible for studying the genomic sequence of type chronic lymphocytic leukemia, the most common among adults in Western countries and that, generally, is not curable with treatment strategies available. This scientific work is part of our participation in the largest international research project on cancer genomics, an initiative which will involve seven other countries that are responsible respectively for other types of tumors. The International Consortium of the Cancer Genome (ICGC, in its acronym in Spanish) announced the launch of these eight research projects on two types of the disease to be carried out by 11 institutions.
Spanish
»
English
Translate


No comments: